OUTLOOK THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-06-30 was $26.96M, a 96.50% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2026-03-31 was $6.34M, a 349.28% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-12-31 was $14.88M, a 756.96% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $13.72M, a 191951.63% increase year-over-year.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $25.03M, a 26855.27% increase from fiscal 2024.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $92.86K, a 99.69% decline from fiscal 2023.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $30.24M, a 51.44% decline from fiscal 2022.
- OUTLOOK THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $62.26M, a 34.01% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2026-06-30 | $26.96M 10-Q · filed 2026-08-18 | |
| 2026-03-31 | $6.34M 10-Q · filed 2026-08-18 | |
| 2025-12-31 | $14.88M 10-Q · filed 2026-08-18 | |
| 2025-09-30 | $25.03M 10-K · filed 2025-12-19 | |
| 2025-06-30 | $13.72M 10-Q · filed 2026-08-18 | |
| 2025-03-31 | $1.41M 10-Q · filed 2026-08-18 | |
| 2024-12-31 | $1.74M 10-Q · filed 2026-08-18 | |
| 2024-09-30 | $92.86K 10-K · filed 2025-12-19 | |
| 2024-06-30 | $7.14K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $85.71K 10-Q · filed 2025-08-14 | |
| 2023-09-30 | $30.24M 10-K · filed 2024-12-27 | |
| 2023-06-30 | $3.30M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $24.29M 10-Q · filed 2024-08-14 | |
| 2022-09-30 | $62.26M 10-K · filed 2023-12-22 | |
| 2022-06-30 | $291.50K 10-Q · filed 2023-08-14 | $64.49M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $2.89M 10-Q · filed 2023-08-14 | $67.30M derived: sum of 4 quarters · filed 2023-08-14 |
| 2021-12-31 | $57.46M 10-Q · filed 2023-08-14 | $103.92M derived: sum of 4 quarters · filed 2023-08-14 |
| 2021-09-30 | $3.85M derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-29 | $46.46M 10-K · filed 2022-12-29 |
| 2021-06-30 | $3.10M 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $39.52M 10-Q · filed 2022-08-10 | |
| 2020-09-30 | $997.77K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-23 | $35.35M 10-K · filed 2021-12-23 |
| 2020-06-30 | $25.15M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $9.20M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | $26.16M 10-K · filed 2020-12-23 |
| 2019-06-30 | $26.16M 10-Q · filed 2020-08-14 | |
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-19 | $6.38M 10-K · filed 2019-12-19 |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 | $6.38M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | $7.31M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | $6.38M 10-Q · filed 2019-02-14 | |
| 2017-09-30 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-18 | $1.50M 10-K · filed 2018-12-18 |
| 2017-06-30 | $927.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-14 | |
| 2016-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-29 | $16.14M 10-K · filed 2017-12-29 |
| 2016-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | |
| 2015-09-30 | $44.14M 10-K · filed 2016-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |